Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee
DSMC concluded that Phase 1 study may continue as planned without any modifications On track to complete the enrollment of...